Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$848M |
| 2 |
Tesla
TSLA
|
+$759M |
| 3 |
Home Depot
HD
|
+$653M |
| 4 |
Meta Platforms (Facebook)
META
|
+$567M |
| 5 |
Wells Fargo
WFC
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$409M |
| 3 |
Micron Technology
MU
|
+$379M |
| 4 |
AT&T
T
|
+$372M |
| 5 |
Medtronic
MDT
|
+$370M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.69% |
| 2 | Technology | 14.95% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Consumer Staples | 10.7% |
| 5 | Communication Services | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
MiMedx Group
MDXG
$622M
| $1.47M | ﹤0.01% |
312,385
+134,085
| +75% | +$656K |
|
2452
Northern Technologies International Corp
NTIC
$79.9M
| $1.47M | ﹤0.01% |
122,077
-11,400
| -9% | -$150K |
|
|
LITB
2453
LightInTheBox
LITB
$58.9M
| $1.46M | ﹤0.01% |
232,437
-5,250
| -2% | -$35.1K |
|
2454
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.9B
| $1.46M | ﹤0.01% |
16,000
-55,900
| -78% | -$5.11M |
|
2455
VistaGen Therapeutics
VTGN
$10.1M
| $1.46M | ﹤0.01% |
+39,283
| New | +$1.71M |
|
2456
Viant Technology
DSP
$245M
| $1.46M | ﹤0.01% |
222,692
+116,792
| +110% | +$891K |
|
2457
Espey Mfg & Electronics Corp
ESP
$181M
| $1.46M | ﹤0.01% |
104,812
-4,100
| -4% | -$54.6K |
|
2458
Hooker Furnishings Corp
HOFT
$160M
| $1.46M | ﹤0.01% |
76,865
+64,365
| +515% | +$1.37M |
|
|
QQQH
2459
NEOS Nasdaq-100 Hedged Equity Income ETF
QQQH
$378M
| $1.45M | ﹤0.01% |
29,600
-20,350
| -41% | -$1.03M |
|
|
LAND
2460
Gladstone Land Corp
LAND
$348M
| $1.45M | ﹤0.01% |
39,800
+27,100
| +213% | +$875K |
|
|
ICD
2461
DELISTED
Independence Contract Drilling, Inc.
ICD
| $1.45M | ﹤0.01% |
351,000
+46,975
| +15% | +$185K |
|
2462
BK Technologies
BKTI
$300M
| $1.45M | ﹤0.01% |
113,627
-5,953
| -5% | -$74.4K |
|
2463
First Bancorp
FBNC
$2.64B
| $1.45M | ﹤0.01% |
+34,631
| New | +$1.55M |
|
2464
Privia Health
PRVA
$3B
| $1.45M | ﹤0.01% |
+54,100
| New | +$1.28M |
|
|
SHOE
2465
Shoe Station Group
SHOE
$419M
| $1.45M | ﹤0.01% |
49,575
-14,793
| -23% | -$482K |
|
|
TWKS
2466
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $1.45M | ﹤0.01% |
69,500
-67,600
| -49% | -$1.48M |
|
2467
MBIA
MBI
$266M
| $1.45M | ﹤0.01% |
93,874
-46,700
| -33% | -$688K |
|
2468
AnaptysBio
ANAB
$1.59B
| $1.44M | ﹤0.01% |
58,300
+23,700
| +68% | +$717K |
|
2469
Embotelladora Andina Series A
AKO.A
$3.66B
| $1.44M | ﹤0.01% |
132,300
-4,300
| -3% | -$46.2K |
|
2470
Clearwater Paper
CLW
$359M
| $1.44M | ﹤0.01% |
51,300
-3,100
| -6% | -$97.3K |
|
|
SEEL
2471
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $1.44M | ﹤0.01% |
+447
| New | +$1.92M |
|
2472
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.8B
| $1.44M | ﹤0.01% |
9,600
-6,500
| -40% | -$956K |
|
|
BLU
2473
DELISTED
BELLUS Health Inc.
BLU
| $1.44M | ﹤0.01% |
207,649
+179,011
| +625% | +$1.15M |
|
|
CNCE
2474
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $1.44M | ﹤0.01% |
426,305
-149,500
| -26% | -$474K |
|
2475
First Internet Bancorp
INBK
$261M
| $1.43M | ﹤0.01% |
33,300
-19,100
| -36% | -$924K |
|
Similar funds
Renaissance Technologies's Q1 2022 Portfolio in Review
As of Q1 2022, Renaissance Technologies held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.
- Renaissance Technologies's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
- Renaissance Technologies added most to Tesla in Q1 2022, an estimated $759M increase.
- Renaissance Technologies's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
- Renaissance Technologies fully exited Microsoft in Q1 2022, selling an estimated $786M.
- Renaissance Technologies's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
- Renaissance Technologies opened 822 new positions and closed 650 in Q1 2022.
- Renaissance Technologies's portfolio value rose 6% quarter-over-quarter to $85.2B.
Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.